Pharma & Healthcare Firms Plan ₹13,000 Crore IPO Pipeline Over Coming 9 Months
Pharma and healthcare companies to raise ₹13,000 crore via IPOs as sector growth fuels investor optimism
MUMBAI, Sept 25: India’s pharmaceutical and healthcare sector is gearing up for a fundraising spree, with companies preparing initial public offerings (IPOs) worth nearly ₹13,000 crore over the next nine months, according to investment banking sources.
The upcoming IPOs reflect the sector’s robust growth prospects, rising investor appetite, and the increased focus on healthcare innovation post-pandemic. Analysts say the listings will provide a significant boost to both the companies’ expansion strategies and the broader equity market.
Industry experts highlight that strong domestic consumption, export potential, and digital healthcare adoption are key drivers attracting investors to pharma and healthcare IPOs. With several companies already filing draft papers with SEBI, market participants expect the IPO pipeline to strengthen further as FY25 unfolds.
If successfully executed, the offerings could make pharma and healthcare one of the largest fundraising sectors in the IPO market this year, second only to financial services.
Market watchers also point out that retail investors are likely to participate actively, given the sector’s resilience and consistent long-term demand.
